HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit

Featuring perspectives from Dr Aditya Bardia, Dr Virginia F Borges, Dr Harold J Burstein and Dr Joyce O'Shaughnessy, including the following topics:

• Introduction (0:00)
• CDK4/6 Inhibitors for HR-Positive Metastatic Breast Cancer (mBC) — Dr Borges (9:56)
• Targeting the PTEN/PI3K/AKT Pathway in HR-Positive mBC — Dr Burstein (35:20)
• Role of Oral Selective Estrogen Receptor Degraders in the Management of HR-Positive mBC — Dr O'Shaughnessy (1:03:07)
• Antibody-Drug Conjugates for HR-Positive mBC — Dr Bardia (1:36:12)

CME information and select publications